Literature DB >> 10640441

Autocrine regulation of TGF beta expression in adult cardiomyocytes.

G Taimor1, K D Schlüter, K Frischkopf, M Flesch, S Rosenkranz, H M Piper.   

Abstract

As shown before, TGF beta acts in an autocrine manner on the induction of hypertrophic responsiveness to beta-adrenoceptor stimulation in cultured ventricular cardiomyocytes of adult rat. We now investigated how TGF beta expression and activation is regulated in these cultures and how beta-adrenoceptor stimulation influences TGF beta -mRNA expression. It was found that freshly isolated cardiomyocytes secrete latent TGF beta in the culture medium. Supplementation of the cultures with 20% FCS resulted in activation of the secreted TGF beta to 4.1+/-0.2 ng/ml active TGF beta after 6 days. Presence of the protease inhibitor aprotinin (50 microg/ml) reduced TGF beta activity by 44+/-5% (n=5, P<0.05). In cultures supplemented with 5% FCS, TGF beta was not activated. Active TGF beta downregulated its mRNA-expression: after 6 days TGF beta(1)-mRNA was reduced to 55.1+/-11.0%, TGF beta(2)-mRNA to 30.1+/-16.5%, and TGF beta(3)-mRNA to 0.3+/-0.4% in 20% FCS-cultures as compared to their expression in freshly isolated cells (n=4, P<0.05). TGF beta-mRNA expression did not change in cultures without active TGF beta. Isoprenaline (1 microm) increased TGF beta(1)-mRNA only in cultures which had been pre-exposed to active TGF beta. This effect was also seen when hearts from normal mice were compared with hearts from transgenic mice overexpressing TGF beta(1): only in hearts from transgenic animals perfusion with isoprenaline increased TGF beta(1)-mRNA. In conclusion, isolated cardiomyocytes release latent TGF beta, which is activated by external proteases. Active TGF beta downregulates its own mRNA expression. Preexposure to TGF beta is necessary for a beta-adrenoceptor-mediated increase in TGF beta(1)-mRNA in cardiomyocytes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640441     DOI: 10.1006/jmcc.1999.1055

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.

Authors:  Panagiotis Flevaris; Sadiya S Khan; Mesut Eren; Adam J T Schuldt; Sanjiv J Shah; Daniel C Lee; Sweta Gupta; Amy D Shapiro; Paul W Burridge; Asish K Ghosh; Douglas E Vaughan
Journal:  Circulation       Date:  2017-06-06       Impact factor: 29.690

2.  CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation.

Authors:  Michael Grimm; Haiyun Ling; Andrew Willeford; Laetitia Pereira; Charles B B Gray; Jeffrey R Erickson; Satyam Sarma; Jonathan L Respress; Xander H T Wehrens; Donald M Bers; Joan Heller Brown
Journal:  J Mol Cell Cardiol       Date:  2015-06-14       Impact factor: 5.000

Review 3.  Transforming growth factor beta in cardiovascular development and function.

Authors:  Mohamad Azhar; Jo El J Schultz; Ingrid Grupp; Gerald W Dorn; Pierre Meneton; Daniel G M Molin; Adriana C Gittenberger-de Groot; Thomas Doetschman
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

4.  Encapsulated pheochromocytoma cells secrete potent noncatecholamine factors.

Authors:  Hector R Mobine; George C Engelmayr; Nelson Moussazadeh; Tayyba R Anwar; Lisa E Freed; Elazer R Edelman
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

5.  Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis.

Authors:  Yong Li; William Foster; Bridget M Deasy; Yisheng Chan; Victor Prisk; Ying Tang; James Cummins; Johnny Huard
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 6.  The role of Smad signaling cascades in cardiac fibrosis.

Authors:  Anis Hanna; Claudio Humeres; Nikolaos G Frangogiannis
Journal:  Cell Signal       Date:  2020-11-05       Impact factor: 4.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.